| 000 | 01338 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250512003831.0 | ||
| 264 | 0 | _c19891107 | |
| 008 | 198911s 0 0 eng d | ||
| 022 | _a0361-7742 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDarius, H | |
| 245 | 0 | 0 |
_aPilot study of the effects of taprostene (CG 4203) in patients with advanced peripheral arterial disease. _h[electronic resource] |
| 260 |
_bProgress in clinical and biological research _c1989 |
||
| 300 |
_a417-21 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aArterial Occlusive Diseases _xclassification |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCardiovascular Agents _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aEpoprostenol _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFlushing _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aProstaglandins, Synthetic _xadministration & dosage |
| 700 | 1 | _aKopp, H | |
| 700 | 1 | _aMulfinger, A | |
| 700 | 1 | _aSpielberger, M | |
| 700 | 1 | _aTodt, M | |
| 700 | 1 | _aSchuster, C J | |
| 700 | 1 | _aMeyer, J | |
| 773 | 0 |
_tProgress in clinical and biological research _gvol. 301 _gp. 417-21 |
|
| 999 |
_c2514106 _d2514106 |
||